Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral and intravenous S-ketamine crossover pharmacology study in healthy volunteers
NL-OMON55261Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in major depressive disorder (MDD) (4 arms), sponsored by Centre for Human Drug Research. Started Aug 2021; status: active, not recruiting.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON55261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55261.